| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/20/2007 | CN1984673A Hydrogel interferon formulations |
| 06/20/2007 | CN1984672A Modulation of NKG2D |
| 06/20/2007 | CN1984671A Use of a combination of cyclosporin and pegylated interferons for treating hepatitis c (HCV) |
| 06/20/2007 | CN1984670A Cyclosporins to treat alzheimer's disease |
| 06/20/2007 | CN1984669A 朊病毒特异性的肽试剂 Prion-specific peptide reagent |
| 06/20/2007 | CN1984668A Prouroguanylin, and synthetic analogs or proteolytic cleavage products derived from it, as therapeutic and diagnostic agents for diseases involving salt and/or fluid homeostasis |
| 06/20/2007 | CN1984664A Methods for treating bleeding disorders using sulfated polysaccharides |
| 06/20/2007 | CN1984571A A method of improving nutrient utilisation by a mammal and a composition for use therein |
| 06/20/2007 | CN1982459A Method of preparing mammal cell kinetin synthesis inhibitoroy factor |
| 06/20/2007 | CN1982458A Amphioxus galactose lectin AmphiGAL13-gene and its use |
| 06/20/2007 | CN1982457A Toxic sequential, its preparation and use |
| 06/20/2007 | CN1982456A China amphioxus peptidoglycan recognition protein B.b.PGRP, its production and use |
| 06/20/2007 | CN1982455A Polynucleotide for inhibiting Wnt activity, its encoded polypeptide and use |
| 06/20/2007 | CN1982454A Related gene of osteoporosis, its encoded protein and use |
| 06/20/2007 | CN1982336A Human pancreas glucagon sample peptide-1-derivative, its production and use |
| 06/20/2007 | CN1982331A Recombinant thymus pentapeptide structural analogs, its production and use |
| 06/20/2007 | CN1982330A Methods for preparing purified lipopeptides |
| 06/20/2007 | CN1982329A Biologically active peptide comprising tyrosyl-seryl-valine (YSV) and use thereof |
| 06/20/2007 | CN1981887A Therapeutic use of growth factor, and delivery device, especially for the treatment of intima hyperplasia |
| 06/20/2007 | CN1981872A Use of PUMA in tumor chemoradiotherapy sensibilization |
| 06/20/2007 | CN1981868A Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for treatment of B cell lymphoma |
| 06/20/2007 | CN1981865A Formula and usage for treating acne |
| 06/20/2007 | CN1981745A Pharmaceutical formulations |
| 06/20/2007 | CN1322134C Expression system |
| 06/20/2007 | CN1322126C Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance |
| 06/20/2007 | CN1322114C Anti-tumor and antiviral medicine and production method thereof |
| 06/20/2007 | CN1322016C Cyclodextrin grafted biocompatible amphiphilic polymer and methods of preparation and use thereof |
| 06/20/2007 | CN1322011C Chain antibiotics / granul cell-macrophage colong stimulating factor fusion protein |
| 06/20/2007 | CN1322007C Antibacterial peptide DC and its preparing process and use |
| 06/20/2007 | CN1321702C Wound dressing for first aid |
| 06/20/2007 | CN1321695C Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 06/20/2007 | CN1321692C Medicinal composition for treating arthritis |
| 06/20/2007 | CN1321691C Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition in form of a kit |
| 06/20/2007 | CN1321690C Use of recommbined human lysozyme in preparation of medicine for bronchial asthma |
| 06/20/2007 | CN1321689C Use of disintegrain domain of adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 06/20/2007 | CN1321688C Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 06/20/2007 | CN1321687C Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
| 06/20/2007 | CN1321685C Peptidoglycan immunopotentiator and its production process |
| 06/20/2007 | CN1321684C Method of extracting rainbow conk saccharide peptide for injection in rainbow conk saccharided peptide crude product obtained from submerged fermentation |
| 06/20/2007 | CN1321683C Use of neurotoxin therapy for treatment of urologic and related disorders |
| 06/20/2007 | CN1321682C New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 06/20/2007 | CN1321681C Methods and compositions for treatment and repair of defects or lesions in cartilage or bone using functional barrier |
| 06/20/2007 | CN1321585C Animal polypeptide containing bee honeydew |
| 06/19/2007 | US7232924 Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| 06/19/2007 | US7232894 Method for the production of recombinant peptides with a low amount of trisulfides |
| 06/19/2007 | US7232890 Diagnosis, therapy of breast cancer; adjustment of gene expression |
| 06/19/2007 | US7232887 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 06/19/2007 | US7232886 Method for the manufacture of recombinant unhydroxylated collagen polypeptide fibres, and recombinant unhydroxylated collagen polypeptide fibres obtained thereby |
| 06/19/2007 | US7232881 Peptide containing Ser-Ser-Ser-Arg |
| 06/19/2007 | US7232880 Mutant IGFBP-3 molecules that do not bind to IGFS, but retain their ability to functionally bind IGFBP-3 receptor |
| 06/19/2007 | US7232879 complex consisting of a divalent metal cation associated with and capable of co-precipitating with such a peptide for enhancing the expression of insulin from mammalian pancreatic B-type islet cells |
| 06/19/2007 | US7232830 Administering to a patient a compound for increasing neuronal metabolism of histamine to a histamine H2 agonist, to stimulate production of adenosine 3*,5*- cyclic phosphate at a level which maintains myelin against self degeneration |
| 06/19/2007 | US7232818 Compounds for enzyme inhibition |
| 06/19/2007 | US7232806 Small temporal RNA rannging from 21 and 22 base pairs for use regulatory modulators of gene expression; treatment and prevention of cell proliferative disorders |
| 06/19/2007 | US7232804 Use of KPV tripeptide for dermatological disorders |
| 06/19/2007 | US7232803 Molecule comprising backbone of 2-35 non-hydrogen atoms in length, having covalently attached bulky lipoophilic groups and having more cationic than anionic moiety in manufacturing medicament for destabilising microbial cell membranes |
| 06/19/2007 | US7232802 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 06/19/2007 | US7232801 Administering a peptide whose sequence coincide with regions of the IL-16 receptor (CD4) to interfere with or prevent binding to an IL-16 receptor; treating asthma, arthritis, IBD, Systemic Lupus, multiple sclerosis, Graves opthalmopathy, atopic rhinitis, atopic dermatitis and bullous pemphigoid |
| 06/19/2007 | US7232800 for a cleavage reagent while preserving the anti-microbial activity; reagent includes alkaline protease such as trypsin and clotrispain; genetic engineering |
| 06/19/2007 | US7232799 Mixtures of a modified group A streptogramin containing an oxazole ring with a natural, semi-synthetic or synthetic group B streptogramin, e.g., pristinamycin IA, pristinamycin IB, IC, ID, IE, IF, or IG; virginiamycin S1, S3, S4, B, or C; or etamycin; low toxicity |
| 06/19/2007 | US7232798 Neuroprotection and neuroegenisis by administering cyclic prolyl glycine |
| 06/19/2007 | US7232797 Erythropoietin dosing regimen for treating anemia |
| 06/19/2007 | US7232796 Polypeptide for use as a medicament for treating bone defects, bone diseases and for improving bone regeneration |
| 06/19/2007 | US7232683 Extracellular matrix signaling molecules |
| 06/19/2007 | US7232682 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 06/19/2007 | US7232678 Identification of oligoadenylate synthetase-like genes |
| 06/19/2007 | US7232677 Nucleotide sequences for use in treatment of digestion defects in plants and animals |
| 06/19/2007 | US7232670 Therapy lysosomal storage disorder other than Fabry Disease caused by a deficiency of a specific protein comprising: producing protein or an active fragment thereof in an insect cell culture, administering the protein |
| 06/19/2007 | US7232660 Bioassay for detection of membrane protein receptor ligand associated with modulation of hodgkin's disease; carrier for delivering diagnostic and cytotoxic agents to tumors; gene therapy |
| 06/19/2007 | US7232576 A lytic enzyme is produced by a bacteria being infected with a bacteriophage specific |
| 06/19/2007 | US7232575 Nutrient supplements and methods for treating autism and for preventing the onset of autism |
| 06/19/2007 | US7232570 ERAAP modulators regulate immune responses |
| 06/19/2007 | US7232569 Type III secretion pathway in aeromonas salmonicida, and uses therefor |
| 06/19/2007 | US7232566 Methods for treating HIV infected subjects |
| 06/19/2007 | US7232563 A fusion proteins having the C-terminal region of the interfero protein is replaced by a C-terminal region of tau proteins; viricides, antiproliferation agents, antiinflammatory agents; lower cytotoxic side effects |
| 06/19/2007 | US7232562 E38N interferon gamma polypeptide variants |
| 06/19/2007 | CA2437468C Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
| 06/19/2007 | CA2276429C Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant |
| 06/19/2007 | CA2195127C Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |
| 06/19/2007 | CA2189690C Novel active peptide and its preparation |
| 06/19/2007 | CA2187741C Colon-specific drug release system |
| 06/19/2007 | CA2185826C Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 06/19/2007 | CA2158745C Inhibitor of vascular endothelial cell growth factor |
| 06/19/2007 | CA2127107C Methods and compositions for reducing blood loss |
| 06/19/2007 | CA2073124C Tumor antigen specific antibody |
| 06/19/2007 | CA2066738C Prevention, treatment and amelioration of a pathology characterized by brain inflammation |
| 06/19/2007 | CA2013582C Method for enhancing transmembrane transport of exogenous molecules |
| 06/16/2007 | CA2557055A1 Peptides for stimulating an immune response against melanoma |
| 06/14/2007 | WO2007067979A2 Targeting vector-phospholipid conjugates |
| 06/14/2007 | WO2007067964A2 Mucosal delivery of stabilized formulations of exendin |
| 06/14/2007 | WO2007067828A2 Glp-2 mimetibodies, polypeptides, compositions, methods and uses |
| 06/14/2007 | WO2007067782A2 Compositions and methods for inducing the activation of immature monocytic dendritic cells |
| 06/14/2007 | WO2007067779A2 Methods and compositions for drug delivery enhancement |
| 06/14/2007 | WO2007067753A2 Methods of reducing side effects in cancer therapy |
| 06/14/2007 | WO2007067602A1 Interleukin-11 compositions and methods of use |
| 06/14/2007 | WO2007067597A2 Methods and compositions for needleless delivery of binding partners |
| 06/14/2007 | WO2007067561A2 Porous calcium phosphate bone material |
| 06/14/2007 | WO2007067519A2 The use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions |
| 06/14/2007 | WO2007066708A1 INDUCTION OF HARD TISSUE FORMATION RELYING ON Wnt5a/SFRP4 SIGNAL SYSTEM |
| 06/14/2007 | WO2007066423A1 Tumor antigen peptide derived from amacr |